Close
RNS Number : 6285P
Hikma Pharmaceuticals Plc
11 February 2019
 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Said Darwazah

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd.  The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.76%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,800,000

d)

Aggregated information

Aggregated volume: 1,800,000

Price: £0.00p

e)

Date of the transaction

7 February 2019

f)

Place of the transaction

Amman

 

 

 Mazen Darwazah

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mazen Darwazah

2

Reason for the notification

a)

Position/status

Executive Vice Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd.  The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.96%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,800,000

d)

Aggregated information

Aggregated volume: 1,800,000

Price: £0.00p

e)

Date of the transaction

7 February 2019

f)

Place of the transaction

Amman

Mohammed 'Ali' Al-Husry

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mohammed 'Ali' Al-Husry

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hikma Pharmaceuticals PLC

b)

LEI

549300BNS685UXH4JI75

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083

b)

Nature of the transaction

 

Pledge by Darhold Limited of 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of J. Safra Sarasin Ltd.  The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.05%.

c)

Price(s) and volume(s)

Price(s): £0.00p

Volume(s): 1,800,000

d)

Aggregated information

Aggregated volume: 1,800,000

Price: £0.00p

e)

Date of the transaction

7 February 2019

f)

Place of the transaction

Amman

 

Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBGGDDRGBBGCB